Author

Davide Seripa

Amsterdam UMC Location Vrije Universiteit AmsterdamORCID 0000-0001-7331-0470Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 3 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:GWAS / association mapping· 4 Organism:human· 4 Approach:statistical model· 4 Assay:GWAS summary statistics· 2 Assay:whole-exome sequencing· 2

Frequent Co-Authors

Antonio DanieleiD· 3 shared Benedetta NacmiasiD· 3 shared Benjamin Grenier‐BoleyiD· 3 shared Carlo MasulloiD· 3 shared Daniela GalimbertiiD· 3 shared Najaf AminiD· 3 shared Oriol Dols‐IcardoiD· 3 shared Paola BossùiD· 3 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Antonio DanieleORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

APOE stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers's disease

Jesper Qvist Thomassen, Hampton L. Leonard, Brittany Ulms, Benjamin Grenier‐Boley, Sami Heikkinen, Pablo García‐González, Atahualapa Castillo-Morales, Masataka Kikuchi, Jungsoo Gim, Han Cao, Fahri Küçükali, Najaf Amin, Dabin Yoon, Itziar de Rojas, Pilar Álvarez Jerez, , Eystein Stordal

This study performs APOE-stratified GWAS to uncover genetic mechanisms underlying Alzheimer's disease risk and response to therapies.

medRxiv · May 7, 2025 · PreprintGenetic & Genomic Medicine

Exome analysis of 22,319 individuals links extremely rare CNVs and 22q11.21 dosage to Alzheimer's risk

Olivier Quenez, Catherine Schramm, Kévin Cassinari, Aude Nicolas, Joan Groeneveld, Guillaume Huguet, Benjamin Grenier‐Boley, Marc Hulsman, G. Bragi Walters, Itziar de Rojas, Anne Rovelet-Lecrux, Sébastien Feuillette, Laetitia Miguel, Anne-Claire Richard, Stéphane Rousseau, , Betty Marije Tijms

The paper analyzes exome data from 22,319 individuals to identify rare CNVs and 22q11.21 dosage as risk factors for Alzheimer's disease.

medRxiv · Oct 28, 2024 · PreprintGenetic & Genomic Medicine

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as novel risk factors for Alzheimers Disease

Henne H. Holstege, Marc Hulsman, Camille Charbonnier, Benjamin Grenier‐Boley, Olivier Quenez, Detelina Grozeva, Jeroen van Rooij, Rebecca Sims, Shahzad Ahmad, Najaf Amin, Penny J. Norsworthy, Oriol Dols‐Icardo, Holger Hummerich, Amit Kawalia, Alzheimer's Disease Neuroimaging Initiative Database, , John Hardy

The paper identifies rare damaging variants in ATP8B4 and ABCA1 as novel risk factors for Alzheimer's Disease using exome sequencing data from 32,558 individuals.

Nature Genetics · Nov 21, 2022Peer-reviewedGenetic & Genomic Medicine

Association between schizophrenia polygenic score and psychotic symptoms in Alzheimer disease: meta-analysis of 11 cohort studies

Byron Creese, Evangelos Vassos, Sverre Bergh, Lavinia Athanasiu, Iskandar Johar, Arvid Rongve, Ingrid Tøndel Medbøen, Miguel Vasconcelos Da Silva, Eivind Aakhus, Fred Andersen, Francesco Bettella, Anne Brækhus, Srdjan Djurovic, Giulia Paroni, Petroula Proitsi, , Geir Selbæk

This study finds a genetic link between schizophrenia polygenic risk and psychotic symptoms, particularly delusions, in Alzheimer's disease through a meta-analysis of 11 cohort studies.

Translational Psychiatry · Oct 22, 2019Peer-reviewedGenomics